Apr 02, 2019
MEI Pharma to Present at the 18th Annual Needham Healthcare Conference
Mar 12, 2019
MEI Pharma to Present at the 29th Annual Oppenheimer Healthcare Conference
Feb 07, 2019
MEI Pharma Reports Second Quarter Fiscal Year 2019 Results and Operational Highlights
Dec 03, 2018
Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
Dec 02, 2018
MEI Pharma Presents Clinical Data from Ongoing Phase 1b Study of ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Hematology Annual Meeting
Nov 08, 2018
MEI Pharma Reports First Quarter Fiscal Year 2019 Results and Operational Highlights
Nov 06, 2018
MEI Pharma To Present at Stifel 2018 Healthcare Conference
Nov 05, 2018
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
Oct 11, 2018
MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies
Aug 29, 2018
MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference
Aug 23, 2018
MEI Pharma to Release 2018 Fiscal Year End Financial Results and Provide Corporate Update on August 30, 2018
Jul 16, 2018
MEI Pharma Promotes David M. Urso to Chief Operating Officer
Jun 15, 2018
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
Jun 04, 2018
MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 04, 2018
MEI Pharma Presents Clinical Data for ME-344 in HER2 Negative Breast Cancer Patients at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018
MEI Pharma to Present Clinical Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 09, 2018
MEI Pharma Reports Third Quarter Fiscal Year 2018 Results
Feb 26, 2018
MEI Pharma Appoints Industry Veteran Frederick W. Driscoll to its Board of Directors
Feb 13, 2018
MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer
Feb 08, 2018
MEI Pharma Reports Second Quarter Fiscal Year 2018 Results